A high-profile British politician is speaking out about his own faulty hip implant made by Johnson & Johnson subsidiary DePuy Orthopaedics, which has “left him in agony and needing two operations,” according to a BBC story.
The story says Andrew Rothaban, Member of Parliament and defense minister, intends to join with thousands of other people who have filed lawsuits over the all-metal hip implants, which were recalled in 2010. Studies show ...
continue reading...
Johnson & Johnson, the worlds’ largest maker of health care products, has announced that its first-quarter profits were down, but that its earnings nevertheless beat analysts’ estimates.
According to a story in The Star Ledger out of Newark, sales for the quarter rose to $17.5 billion, an increase of 8.5 percent from a year earlier, compared to the $17.46 billion that analysts were predicting.
The story notes that a long-running string of ...
continue reading...A U.S. appeals court has sided with health care giant Johnson & Johnson – throwing out an earlier $482 million verdict in a patent infringement case, according to a story in the Newark Star Ledger.
A doctor had claimed Johnson & Johnson infringed on the patent for his invention, which used a permeable barrier to treat injured tissue. He claimed the company improperly used the technology for a type of stent ...
continue reading...
A Los Angeles jury recently awarded $8.3 million in damages to a man who claimed he suffered metal poisoning from an artificial hip implant manufactured by Johnson & Johnson’s DePuy Orthopaedics division. That was the first of about 10,000 lawsuits over the hip implant to go to trial.
But America isn’t the only country where people are seeking redress after being ...
continue reading...
A woman who received a faulty hip implant that had to be replaced after only three years should get at least $5 million from the company that manufactured it, her lawyer told a Chicago jury.
According to Bloomberg, lawyers gave the closing arguments in the lawsuit against Johnson & Johnson subsidiary DePuy Orthopaedics, which represents the second of nearly 11,000 such cases filed in the United States.
In March 8, a Los ...
continue reading...
A study published in the British Medical Journal concluded that a high concentration of the metal cobalt in a patient’s blood is a “significant risk factor” for failure of an all-metal artificial hip joint, Medscape Today News reports.
In light of the findings, the researchers suggest that health regulators in both the United States and the United Kingdom revise their current recommendations against patients with no symptoms getting routine blood metal ...
continue reading...
